Passamonti F, Cazzola M. Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug. Haematologica [Internet]. 2004Nov.1 [cited 2026Nov.12];89(11):1284-. Available from: https://haematologica.org/article/view/3296